Clinical Trial Update: A Study to Investigate Long-term Safety and Tolerability of Itepekimab in Participants With COPD [Phase 3]

View source ↗

Summary

This document provides an update on a Phase 3 clinical trial evaluating the long-term safety and tolerability of itepekimab in chronic obstructive pulmonary dis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• itepekimab (itepekimab)

Snippet

Sponsor: Sanofi | Conditions: Chronic Obstructive Pulmonary Disease | Phase 3 | Status: ACTIVE_NOT_RECRUITING